H3K9 histone methyltransferase G9a ameliorates dilated cardiomyopathy via the downregulation of cell adhesion molecules

Molecular Medicine Reports

Volumn 11, Issue 5, 2015, Pages 3872-3879

  Chen, Guiying ^a   Wang, Xu ^a   Zhang, Yina ^a   Ru, Xiaoxue ^a   Zhou, Lijun ^a   Tian, Ye ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Animal model; Cell adhesion molecules; Dilated cardiomyopathy; Furazolidone; H3K9 histone methyltransferase G9a

Indexed keywords

CELL ADHESION MOLECULE; FURAZOLIDONE; H3K9 HISTONE METHYLTRANSFERASE G9A; HISTONE METHYLTRANSFERASE; UNCLASSIFIED DRUG; G9A PROTEIN, RAT; HISTONE LYSINE METHYLTRANSFERASE; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; CARDIOVASCULAR PARAMETERS; CELL GROWTH; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE SILENCING; HEART BEAT; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART RIGHT ATRIUM PRESSURE; HEART SIZE; IMMUNOHISTOCHEMISTRY; LEFT VENTRICULAR END DIASTOLIC DIMENSION; LEFT VENTRICULAR END SYSTOLIC DIMENSION; MALE; NEWBORN; NONHUMAN; PRESSURE MEASUREMENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEART VENTRICLE REMODELING; METABOLISM; PATHOPHYSIOLOGY;

ANIMALIA; RATTUS;

ANIMALS; CARDIOMYOPATHY, DILATED; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HISTONE-LYSINE N-METHYLTRANSFERASE; MALE; MYOCYTES, CARDIAC; RATS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; VENTRICULAR REMODELING;

EID: 84922310917     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3218     Document Type: Article

References (43)

1. Linke WA and Bücker S: King of hearts: a splicing factor rules cardiac proteins. Nat Med 18: 660, 2012.
2. Meyer L, Stubbs B, Fahrenbruch C, et al: Incidence, causes and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age a 30-year review. Circulation 126: 1363-1372, 2012.
3. Tachibana M, Sugimoto K, Fukushima T and Shinkai Y: Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem 276: 25309-25317, 2001.
4. Albert M and Peters AH: Genetic and epigenetic control of early mouse development. Curr Opin Genet Dev 19: 113-121, 2009.
5. Feldman N, Gerson A, Fang J, et al: G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8: 188-194, 2006.
6. Chen MW, Hua KT, Kao HJ, et al: H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res 70: 7830-7840, 2010.
7. Devaux B, Scholz D, Hirche A, Klövekorn WP and Schaper J: Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 18: 470-479, 1997.
8. Blankenberg S, Rupprecht HJ, Bickel C, et al: Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104: 1336-1342, 2001.
9. Yin WH, Chen JW, Jen HL, et al: The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Eur J Heart Fail 5: 507-516, 2003.
10. Noutsias M, Seeberg B, Schultheiss H-P and Kühl U: Expression of cell adhesion molecules in dilated cardiomyopathy evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99: 2124-2131, 1999.
11. Watanabe K, Ohta Y, Nakazawa M, et al: Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. Br J Pharmacol 130: 1489-1495, 2000.
12. Chadfield MS and Hinton MH: In vitro activity of nitrofuran derivatives on growth and morphology of Salmonella enterica serotype enteritidis. J Appl Microbiol 96: 1002-1012, 2004.
13. Jankus E, Noren G and Staley N: Furazolidone-induced cardiac dilatation in turkeys. Avian Dis 16: 958-961, 1972.
14. Liao R, Nascimben L, Friedrich J, Gwathmey JK and Ingwall JS: Decreased energy reserve in an animal model of dilated cardiomyopathy relationship to contractile performance. Circ Res 78: 893-902, 1996.
15. Czarnecki CM: Animal models of drug-induced cardiomyopathy. Comp Biochem Physiol Part C 79: 9-14, 1984.
16. Huang RJ, Liu TW, Wu WF and Pang YS: Furazolidone induces dilated cardiomyopathy in rats [J]. Chinese J Pathophysiol 11, 2005.
17. Kubota T, McTiernan CF, Frye CS, et al: Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res 81: 627-635, 1997.
18. Stein AB, Tiwari S, Thomas P, et al: Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol 102: 28-41, 2007.
19. Delles M, Rengier F, Jeong YJ, et al: Estimation of aortic pressure waveforms from 4D phase-contrast MRI. Conf Proc IEEE Eng Med Biol Soc 2013: 731-734, 2013.
20. Patel AR, Alsheikh-Ali AA, Mukherjee J, et al: 3D echocardiography to evaluate right atrial pressure in acutely decompensated heart failure correlation with invasive hemodynamics. JACC Cardiovasc Imaging 4: 938-945, 2011.
21. Goldberg MR, Tanaka W, Barchowsky A, et al: Effects of losartan on blood pressure, plasma renin activity and angiotensin II in volunteers. Hypertension 21: 704-713, 1993.
22. Kodish ME and Katz FH: Plasma renin concentration: comparison of angiotensinase inhibitors and correlation with plasma renin activity and aldosterone. J Lab Clin Med 83: 705-715, 1974.
23. Takano S, Yoshitomi H, Togawa A, et al: Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells. Oncogene 27: 2810-2822, 2008.
24. Guo Z, Wang S, Jiao Q, Xu M and Gao F: RNAi targeting ryanodine receptor 2 protects rat cardiomyocytes from injury caused by simulated ischemia-reperfusion. Biomed Pharmacother 64: 184-190, 2010.
25. Carleton KL: Quantification of transcript levels with quantitative RT-PCR. Methods Mol Biol 772: 279-295, 2011.
26. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA and Lin A: Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Nat Acad Sci USA 98: 6668-6673, 2001.
27. Moon C, Krawczyk M, Ahn D, et al: Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Nat Acad Sci 100: 11612-11617, 2003.
28. Paulus WJ, Tschöpe C, Sanderson JE, et al: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the european society of cardiology. Eur Heart J 28: 2539-2550, 2007.
29. Avolio A: Central aortic blood pressure and cardiovascular risk a paradigm shift? Hypertension 51: 1470-1471, 2008.
30. Bombardini T, Cini D, Arpesella G and Picano E: WEB downloadable software for training in cardiovascular hemodynamics in the (3-D) stress echo lab. Cardiovasc Ultrasound 8: 48, 2010.
31. Vander AJ: Control of renin release. Physiol Rev 47: 359-382, 1967.
32. Gigante B, Rubattu S, Russo R, et al: Opposite feedback control of renin and aldosterone biosynthesis in the adrenal cortex by angiotensin II AT1-subtype receptors. Hypertension 30 (3 Pt 2): 563-568, 1997.
33. Sarafidis PA and Ruilope LM: Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation? Kidney Int 85: 536-546, 2014.
34. Podwysocki B, Simon K and Gladysz A: Activity of angiotensin converting enzyme I and levels of acid alpha glycoprotein in selected liver and biliary tract diseases. Pol Tyg Lek 48: 268-270, 1993 (In Polish).
35. Aoyagi T, Izumi Y, Hiroyama M, et al: Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am J Physiol Renal Physiol 295: F100-F107, 2008.
36. Erdös EG and Skidgel RA: Renal metabolism of angiotensin I and II. Kidney Int Suppl 30: S24-S27, 1990.
37. Johnston CI: Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. J Hypertens 10: S27, 1992.
38. Ohtani K, Yutani C, Nagata S, Koretsune Y, Hori M and Kamada T: High prevalence of atrial fibrosis in patients with dilated cardiomyopathy. J Am Coll Cardiol 25: 1162-1169, 1995.
39. Zhang M, Shan H, Zhu Y-h, Lin L and Wei J: Attenuating effect of estrogen on furazolidone induced cardiomyocyte apoptosis is dependent on p66shc adapter protein. In: cardiology karger allschwilerstrasse 10, ch-4009 Basel, Switzerland: pp 34-34, 2013.
40. Genao A, Seth K, Schmidt U, Carles M and Gwathmey JK: Dilated cardiomyopathy in turkeys: an animal model for the study of human heart failure. Lab Anim Sci 46: 399-404, 1996.
41. Tachibana M, Sugimoto K, Nozaki M, et al: G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16: 1779-1791, 2002.
42. Roopra A, Qazi R, Schoenike B, Daley TJ and Morrison JF: Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. Mol Cell 14: 727-738, 2004.
43. Hohl M, Wagner M, Reil JC, et al: HDAC4 controls histone methylation in response to elevated cardiac load. J Clin Invest 123: 1359-1370, 2013.